The primary objective of this study is to assess the impact of physician's reinforcement using bone marker data on the subject's compliance (at least 50% drug taken) and persistence on treatment after one year in postmenopausal osteoporotic women.

Inclusion Criteria:

• Ambulatory women,
• Caucasian, Oriental or Multiracial
• not previously diagnosed for osteoporosis.

Exclusion Criteria:

• Females of black descent and for the US african american are excluded because of the very low incidence of postmenopausal osteoporosis
• and having used oral or parenteral glucocorticoids (>= 5 mg prednisone or equivalent per day) within 3 months of starting study drug or for more than one month within six months prior to study entry.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.